Clearbridge Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 3,952 shares of REGN stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,952

Previous 1,433 175.79%

Holding current value

$2.83 Million

Previous $1.51 Million 175.83%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $2.58 Million - $3.03 Million	2,519 Added 175.79%	3,952 $4.15 Million
Q2 2024 Aug 27, 2024	BUY	$883.2 - $1071.19 $1.27 Million - $1.54 Million	1,433 New	1,433 $1.51 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $43,580 - $52,656	-80 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $58.6 Million - $76.4 Million	-118,695 Reduced 99.93%	80 $50,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $282 Million - $334 Million	-759,190 Reduced 86.47%	118,775 $48.8 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $2.11 Million - $2.53 Million	6,274 Added 0.72%	877,965 $328 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1.63 Million - $1.89 Million	-4,638 Reduced 0.53%	871,691 $352 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $10.3 Million - $12.5 Million	36,177 Added 4.31%	876,329 $302 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $10.5 Million - $13.1 Million	33,390 Added 4.14%	840,152 $289 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $16.9 Million - $22.1 Million	47,010 Added 6.19%	806,762 $303 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $12.6 Million - $14.7 Million	29,181 Added 3.99%	759,752 $340 Million
Q2 2017 Aug 14, 2017	BUY	N/A	730,571	730,571 $359 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History